Adaptive Biotechnologies Insider Sells $1 Million in Stock After a Doubling in Share Price | The Motley Fool
Adaptive Biotechnologies, a leader in immune-driven diagnostics, reported a notable insider sale after a strong one-year stock performance.

Source: The Motley Fool
Adaptive Biotechnologies, a leader in immune-driven diagnostics, reported a notable insider sale after a strong one-year stock performance.